|
441 |
Reporting of critical care trial abstracts: a comparison before and after the announcement of CONSORT guideline for abstracts
Enthalten in Trials Bd. 18, 21.1.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
442 |
Reporting quality of randomized controlled trials in patients with HIV on antiretroviral therapy: a systematic review
Enthalten in Trials Bd. 18, 28.12.2017, Nr. 1, date:12.2017: 1-12
|
|
|
|
443 |
Research Involvement and Engagement: reflections so far and future directions
Enthalten in Research involvement and engagement Bd. 3, 8.11.2017, Nr. 1, date:12.2017: 1-6
|
|
|
|
444 |
Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions
Enthalten in BMC medical research methodology Bd. 17, 24.2.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
445 |
Response to letter to editor: ‘Comment on Arch et al., Trials. 2016;17:517’
Enthalten in Trials Bd. 18, 26.5.2017, Nr. 1, date:12.2017: 1-4
|
|
|
|
446 |
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Enthalten in Journal of neuroinflammation Bd. 14, 3.1.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
447 |
Review and publication of protocol submissions to Trials – what have we learned in 10 years?
Enthalten in Trials Bd. 18, 16.12.2016, Nr. 1, date:12.2017: 1-5
|
|
|
|
448 |
Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic
Enthalten in Advances in therapy Bd. 35, 21.12.2017, Nr. 1, date:1.2018: 12-30
|
|
|
|
449 |
Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions
Enthalten in Pharmaceutical medicine Bd. 31, 18.7.2017, Nr. 4, date:8.2017: 245-255
|
|
|
|
450 |
Routinely collected data for randomized trials: promises, barriers, and implications
Enthalten in Trials Bd. 19, 11.1.2018, Nr. 1, date:12.2018: 1-9
|
|
Administration
